Annika Wallin

Summary

Affiliation: University Hospital
Country: Sweden

Publications

  1. ncbi The effects of regular inhaled formoterol and budesonide on preformed Th-2 cytokines in mild asthmatics
    A Wallin
    Department of Respiratory Medicine and Allergy, University Hospital, Umea, Sweden
    Respir Med 96:1021-5. 2002
  2. ncbi LPS-induced bronchoalveolar neutrophilia; effects of salmeterol treatment
    Annika Wallin
    Department of Respiratory Medicine and Allergy, University Hospital, Umeå 90185, Sweden
    Respir Med 98:1087-92. 2004
  3. ncbi Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma
    Annika Wallin
    Department of Respiratory Medicine and Allergy, University Hospital, Ume
    J Allergy Clin Immunol 112:72-8. 2003

Detail Information

Publications3

  1. ncbi The effects of regular inhaled formoterol and budesonide on preformed Th-2 cytokines in mild asthmatics
    A Wallin
    Department of Respiratory Medicine and Allergy, University Hospital, Umea, Sweden
    Respir Med 96:1021-5. 2002
    ..Thus, while budesonide has effects on cytokines involved in eosinophil recruitmentthis explanation does not apply tothe eosinopaenia observed with the long-acting beta2 adrenoreceptor agonist formoterol...
  2. ncbi LPS-induced bronchoalveolar neutrophilia; effects of salmeterol treatment
    Annika Wallin
    Department of Respiratory Medicine and Allergy, University Hospital, Umeå 90185, Sweden
    Respir Med 98:1087-92. 2004
    ..01). The neutrophilia was present irrespective of the LPS inhalation was preceded by placebo or Salmeterol. This experimental study could not confirm any modulating effect of Salmeterol on LPS-induced airway neutrophilia...
  3. ncbi Effect of inhaled fluticasone with and without salmeterol on airway inflammation in asthma
    Annika Wallin
    Department of Respiratory Medicine and Allergy, University Hospital, Ume
    J Allergy Clin Immunol 112:72-8. 2003
    ..CONCLUSION: These findings confirm that addition of SALM to FP has clinical benefits but does not mask or exacerbate airway inflammation and suggest that long-acting beta(2)-adrenoceptor agonists might influence mast cell numbers...